1. Home
  2. IKT vs BW Comparison

IKT vs BW Comparison

Compare IKT & BW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.50

Market Cap

111.8M

Sector

Health Care

ML Signal

HOLD

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

HOLD

Current Price

$5.85

Market Cap

119.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IKT
BW
Founded
2008
1867
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
111.8M
119.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IKT
BW
Price
$1.50
$5.85
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
N/A
$5.50
AVG Volume (30 Days)
354.4K
4.7M
Earning Date
11-14-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$721,285,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
80.30
52 Week Low
$1.33
$0.22
52 Week High
$4.20
$7.77

Technical Indicators

Market Signals
Indicator
IKT
BW
Relative Strength Index (RSI) 46.90 52.51
Support Level $1.40 $5.66
Resistance Level $1.61 $6.92
Average True Range (ATR) 0.11 0.65
MACD -0.01 -0.11
Stochastic Oscillator 38.46 24.11

Price Performance

Historical Comparison
IKT
BW

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

Share on Social Networks: